ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric - Azide and BSA Free, Novus Biologicals™

ErbB2/Her2

Monoclonal

Unconjugated

PBS with 0.02% Proclin 300. with 0.02% Proclin 300

ERBB2

A431 cells (human epidermoid carcinoma) (over)expressing EGFR.

0.2 mg

Breast Cancer, Cancer, Cellular Markers, Core ESC Like Genes, Oncogenes, Protein Kinase, Stem Cell Markers, Tumor Suppressors

2064

Human

Purified

Flow Cytometry, ELISA, Immunohistochemistry, CyTOF

4D5-8 (trastuzumab)

Flow Cytometry 1:10 - 1:1000, ELISA 1:100 - 1:2000, Immunohistochemistry 1:10 - 1:500, CyTOF-ready

CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian)

Rabbit

Protein A or G purified

RUO

Primary

Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

IgG